Skip to main content
TipRanks
Go Ultimate75% OFF

Clorox (1CLX) Q1 2027 Earnings Report

0 Followers

IT:1CLX Q1 2027 EPS Results

Actual EPS
EUR 1.41
Consensus EPS
EUR 0.98
Beat/Miss
Beat by +EUR 0.44
One Year Ago EPS
EUR 0.78

IT:1CLX Q1 2027 Revenue Results

Actual Revenue
EUR 1.74B
Expected Revenue
EUR 1.71B
Beat/Miss
Beat by +EUR 26.37M
YoY Revenue Growth
+33.31%

Earnings Announcement Details

Quarter
Q1 2027
Date
11/02/2026
Time
After Close
Conference Call
Monday, November 2, 2026
IT:1CLX Upcoming Earnings

Clorox's next earnings date is estimated for February 4, 2027, based on past reporting schedules.

Q1 2027 Earnings Call Audio

IT:1CLX Q1 2027 Earnings Call
0:00 / 0:00

Q1 2027 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2027 Earnings Call Summary

Q1 2027
Earnings Call Date:Nov 02, 2026|% Change Since:21.09%|
Earnings Call Sentiment|Positive

The call was cautiously optimistic. Clorox reported a better-than-expected start, improving consumption and market-share trends, strong cost savings, positive GOJO integration progress and a robust innovation pipeline. However, these positives are being offset in the near term by $240 million of input cost inflation, front-half gross-margin compression, modest organic sales growth excluding the ERP benefit, elevated competition, consumer value-seeking behavior and continued weakness in Cat Litter. Overall, the highlights outweigh the lowlights, but management remains focused on executing a gradual recovery.

Company Guidance

Management expects fiscal year organic sales growth of 3.5% to 4.5%, including about 3.5 points of benefit from lapping the ERP transition, or flat to plus 1% excluding the ERP; excluding the ERP, growth is expected to be down slightly in the front half and up slightly in the back half, while category growth is expected to be flat to up 1%. Input cost inflation is expected to be about $240 million, about $40 million more than initially expected and about 2.5x higher our historical annual average rate, assuming Brent annual average price would be around $100, with inflation more pronounced in the first half than in the second half. The company expects gross margin compression on average for the full year, with the front half about 1 point, 1.5 below the average and the back half higher, while SG&A moved from 16% to 15%; the long-term objective remains historical EBIT margin of about 18% and historical gross margin of 43.5% and 44%. Cost synergies from GOJO are estimated at about $50 million, with line of sight to the entire $50 million and potentially more.

  • Better-Than-Expected First-Quarter PerformanceClorox delivered better-than-expected fiscal year 2027 first-quarter results through strong execution and favorable timing benefits. Management said the underlying trajectory is improving, with steady progress in organic sales growth and market share.
  • Full-Year Organic Sales OutlookFull-year organic sales growth is expected to be 3.5% to 4.5%, including about 3.5 points of benefit from lapping the ERP transition. Excluding the ERP impact, organic sales growth is expected to be flat to plus 1%.
  • Expected Sequential Improvement in Sales and ConsumptionOrganic sales growth excluding the ERP impact is expected to be down slightly in the front half and up slightly in the back half. Annual retail consumption is expected to be essentially flat in the front half and up slightly in the back half, improving from low negative-single-digit trends at the start of the prior fiscal year.
  • Broad-Based Market Share MomentumHome Care share increased by over 0.5 share point, driven in large part by innovation activation and back-to-school merchandising. Brita also posted strong share growth, supported by back-to-school and back-to-college merchandising, promotions and innovation.
  • Hidden Valley Share GainsHidden Valley grew nearly 2 share points during the quarter despite significant category pressure related to the cyclospora outbreak. Management attributed the performance to strong execution and the brand's use beyond salads.
  • Kingsford Labor Day PerformanceKingsford delivered very strong high single-digit growth during the Labor Day period along with share growth, which management said was a positive indication following execution adjustments.
  • GOJO Integration and Synergy ProgressThe first-year adjusted EPS impact from the GOJO acquisition was revised from approximately neutral to positive. Clorox has line of sight to at least the full $50 million of estimated cost synergies and has begun accelerating some synergies into fiscal year 2027.
  • Strong Quarterly Cost SavingsFirst-quarter cost savings were among the highest quarterly levels on record. Management said the productivity engine is stronger than in the past, supported by RGM, design-to-value and data- and technology-driven capabilities.
  • ERP Entering Value-Creation PhaseFollowing implementation and stabilization, the ERP program is entering a value-creation phase. Management expects cost complexity to decline and ERP-related benefits to ramp up over the next few years, with some benefits expected later in the current fiscal year.
  • Strong Innovation PipelineClorox has one of its strongest innovation plans on record, with most launches scheduled for the back half of the fiscal year. Management reported good retailer sell-in and said many innovations had very strong consumer testing results, including extensions of successful platforms such as Clorox PURE.
  • Targeted Pricing and RGM ActionsClorox implemented targeted pricing across all four reporting segments, including a high single-digit price increase on Glad Trash in July. The company expects additional targeted pricing and RGM initiatives in the back half, while the vast majority of the portfolio will be covered by RGM activity.
  • Health and Wellness Price/Mix StrengthHealth and Wellness delivered approximately 7% favorable price/mix. About 6 percentage points came from the GOJO acquisition, while approximately 1 percentage point came from the base business through RGM and targeted pricing on smaller brands.
  • Long-Term Margin Recovery PlanManagement reaffirmed a long-term objective of returning to approximately 18% historical EBIT margins. Historical gross margin was cited at 43.5% to 44%, and the company plans to rebuild gross margin through productivity, cost savings, RGM, pricing and GOJO synergies before rationalizing OpEx over time.
  • Continued Investment in Brand SuperiorityClorox is continuing to invest in brand superiority, innovation, advertising, sales promotion, trade funds, product improvements and e-commerce execution. Advertising and sales promotion spending is approximately 11% overall versus about 10% historically, and approximately 12% in U.S. retail excluding the GOJO effect.
  • CEO Succession and Transition PlanThe Board appointed Fabian Garcia as the next CEO. Management described him as an experienced global consumer products leader with a track record in brand building, portfolio evolution, talent development and disciplined growth. Linda Rendle plans to remain focused on execution through January 5 while supporting a seamless transition.

IT:1CLX Earnings History

IT:1CLX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 04, 20272027 (Q2)0.90-1.27――
Nov 02, 20262027 (Q1)0.981.410.7882.35% (+0.64)
Aug 03, 20262026 (Q4)1.501.512.62-42.16% (-1.10)
Apr 30, 20262026 (Q3)1.411.501.3213.10% (+0.17)
Feb 03, 20262026 (Q2)1.311.271.41-10.32% (-0.15)
Nov 04, 20252026 (Q1)0.710.781.7-54.30% (-0.92)
Jul 31, 20252025 (Q4)2.012.621.6657.69% (+0.96)
May 05, 20252025 (Q3)1.411.321.56-15.20% (-0.24)
Feb 03, 20252025 (Q2)1.281.411.97-28.24% (-0.56)
Oct 30, 20242025 (Q1)1.291.700.45279.59% (+1.25)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed